Patient centricity is fast becoming the “new normal” in the biopharma industry
Engaging with patients, actively listening and incorporating their insights adds value throughout all phases of drug development
Patient centricity is optimized when implemented across all disciplines including clinical development, medical affairs, market access, outcomes research and commercialization.
Presented by: Bruce Crawford, MA, MPH, Vice President, Real World & Late Phase
